A randomized phase II trial of geriatric assessment and management for older cancer patients.
Martine T E PutsSchroder SattarMichael KulikMary Ellen MacDonaldKara McWattersKatherine LeeSarah BrennenstuhlRaymond JangEitan AmirMonika K KrzyzanowskaAnthony M JoshuaJohanne MonetteDoreen Wan-Chow-WahShabbir M H AlibhaiPublished in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2017)
This trial showed that it was feasible to recruit and retain older adults for a GAM study. Those who survived at least 6 months seemed to receive a greater QOL benefit than those who died or withdrew.